InsiderSignal.AI

InsiderSignal.ai

ERNA - Ernexa Therapeutics Inc.

Insider Purchase by Cherington Charles (10%)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

1 week ago, Cherington Charles, serving as 10% owner at Ernexa Therapeutics Inc. (ERNA), purchased 4,000,000 shares at $0.50 per share, for a total transaction value of $2,000,000.00. Following this transaction, Cherington Charles now holds 6,779,440 shares of ERNA.

This purchase represents a 144.00% increase in Cherington Charles's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, February 10, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, February 17, 2026, 7 days after the trade was made.

Ernexa Therapeutics Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Cherington Charles

Cherington Charles

10%

Charles Cherington is a seasoned private equity executive and the co-founder and Managing Partner of Ara Partners, a global private equity firm focused on industrial decarbonization investments, established in 2017.[[1]](https://boards.industrial-linguistics.com/directors/charles+cherington.html)[[2]](https://www.arapartners.com/our-firm/our-team/charles-cherington/) He co-heads the firm with Troy Thacker and serves on its Investment Committee, bringing over 30 years of experience in the industrial, energy, and chemical sectors, with more than 50 transactions executed.[[2]](https://www.arapartners.com/our-firm/our-team/charles-cherington/) Previously, Cherington co-founded and managed Intervale Capital (2006-2017), founded Cherington Capital (2002-2006), and was a partner at Paratus Capital Management (1999-2004), alongside early roles at Lochridge & Company and Credit Suisse First Boston.[[1]](https://boards.industrial-linguistics.com/directors/charles+cherington.html)[[2]](https://www.arapartners.com/our-firm/our-team/charles-cherington/) He holds a B.A. in History from Wesleyan University and an M.B.A. with honors from the University of Chicago.[[1]](https://boards.industrial-linguistics.com/directors/charles+cherington.html)[[2]](https://www.arapartners.com/our-firm/our-team/charles-cherington/) As a prominent investor, Cherington is a 10% owner of Ernexa Therapeutics Inc. (ERNA), holding approximately 2,777,318 shares as of June 2025, valued at over $7 million, reflecting recent insider trading activity.[[3]](https://www.gurufocus.com/insider/165011/charles-cherington) His portfolio also includes significant stakes in Comera Life Sciences Holdings Inc. (CMRA) and past directorships such as at Beard Energy Transition Acquisition Corp. (BRD).[[3]](https://www.gurufocus.com/insider/165011/charles-cherington) Beyond finance, Cherington is active in land conservation, serving on The Conservation Fund's Board of Directors.[[2]](https://www.arapartners.com/our-firm/our-team/charles-cherington/)

View full insider profile →

Trade Price

$0.50

Quantity

4,000,000

Total Value

$2,000,000.00

Shares Owned

6,779,440

Trade Date

Tuesday, February 10, 2026

12 days ago

SEC Filing Date

Tuesday, February 17, 2026

Filed 7 days after trade

HEALTHCAREBIOTECHNOLOGY

About Ernexa Therapeutics Inc.

Company Overview

No company information available
View news mentioning ERNA

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4074051

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime